MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 27.12.2025
Sundial Growers Operativer Cashflow 2011-2026 | SNDL
Operativer Cashflow Jährlich Sundial Growers
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -155 M | -57.5 M | -113 M | -25.8 M | - | - | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -25.8 M | -155 M | -87.9 M |
Operativer Cashflow anderer Aktien in der Arzneimittelhersteller
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
-14.3 M | - | - | $ 142 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
-99.2 M | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
-166 M | $ 1.14 | -1.72 % | $ 123 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
-12.7 M | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-25.9 M | - | 0.86 % | $ 117 M | USA |
 |
Catalent
CTLT
|
268 M | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
-9.58 M | - | 10.11 % | $ 58.2 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
50.7 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
435 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-4.98 M | - | - | $ 36.6 M | USA |
 |
Aurora Cannabis
ACB
|
-211 M | $ 4.22 | -0.94 % | $ 86.3 M | Canada |
 |
DURECT Corporation
DRRX
|
-34.4 M | - | - | $ 50.1 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-462 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-43.1 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Emergent BioSolutions
EBS
|
-206 M | $ 12.36 | 1.64 % | $ 633 M | USA |
 |
Jupiter Wellness
JUPW
|
-7.57 M | - | - | $ 33.6 M | USA |
 |
Athenex
ATNX
|
-131 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-46.9 M | $ 21.55 | 0.05 % | $ 2.05 B |  France |
 |
Evolus
EOLS
|
-18 M | $ 6.65 | -0.3 % | $ 412 M | USA |
 |
Harrow Health
HROW
|
3.84 M | $ 49.0 | -2.04 % | $ 1.6 B | USA |
 |
China Pharma Holdings
CPHI
|
-466 K | $ 1.21 | -9.02 % | $ 21.1 M |  China |
 |
Neoleukin Therapeutics
NLTX
|
-51.4 M | - | - | $ 193 M | Canada |
 |
OrganiGram Holdings
OGI
|
-28.6 M | $ 1.68 | -1.18 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
1.03 B | $ 6.95 | -0.57 % | $ 2.54 B | Canada |
 |
Organogenesis Holdings
ORGO
|
14.2 M | $ 5.18 | - | $ 682 M | USA |
 |
Lannett Company
LCI
|
-7.12 M | - | 1.15 % | $ 7.11 M | USA |
 |
Pacira BioSciences
PCRX
|
189 M | $ 25.88 | -0.73 % | $ 1.2 B | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-612 K | $ 3.98 | 0.51 % | $ 56 M | USA |
 |
Radius Health
RDUS
|
-22.4 M | - | - | $ 1.42 B | USA |
 |
Rockwell Medical
RMTI
|
-9.41 M | $ 0.83 | 2.18 % | $ 19.4 M | USA |
 |
PetIQ
PETQ
|
61.9 M | - | 1.64 % | $ 400 M | USA |
 |
Perrigo Company plc
PRGO
|
363 M | $ 13.92 | -0.14 % | $ 1.91 B | USA |
 |
ProPhase Labs
PRPH
|
28.6 M | $ 0.45 | -1.28 % | $ 7.13 M | USA |
 |
Recro Pharma
REPH
|
-1 M | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-51.7 M | $ 4.83 | 6.62 % | $ 145 M | USA |
 |
OptiNose
OPTN
|
-20.5 M | - | - | $ 1.08 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-88 K | $ 3.64 | 0.64 % | $ 4.52 M | USA |
 |
Assertio Holdings
ASRT
|
49.6 M | $ 9.07 | -1.41 % | $ 644 M | USA |
 |
PLx Pharma
PLXP
|
-32.1 M | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-100 M | $ 5.64 | -1.05 % | $ 230 M | USA |
 |
SCYNEXIS
SCYX
|
60.2 M | $ 0.63 | 4.43 % | $ 30.1 M | USA |
 |
Tricida
TCDA
|
-140 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
7.91 M | $ 9.03 | 0.11 % | $ 5.58 B | Canada |
 |
Veru
VERU
|
-21.7 M | $ 2.14 | -1.38 % | $ 289 M | USA |
 |
TherapeuticsMD
TXMD
|
-159 M | $ 1.63 | -0.61 % | $ 17 M | USA |
 |
Viatris
VTRS
|
3 B | $ 12.45 | -0.72 % | $ 15.1 B | USA |
 |
cbdMD
YCBD
|
-353 K | $ 1.35 | -0.37 % | $ 5.82 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-23 M | - | - | $ 55.5 M | USA |